115 Introduction of biosimilars (similar biological) as financial saving to our countries for rheumatic diseases
Crossref DOI link: https://doi.org/10.1136/lupus-2019-lsm.115
Published Online: 2019-04-05
Published Print: 2019-04
Update policy: https://doi.org/10.1136/crossmarkpolicy
Abdalfattah, Shereen
